Table 3.
Follow-up
| Follow-up | n = 40 |
|---|---|
| Angiographic follow-up | 13 (32.5%) |
| Angiographic follow-up indication | |
| Stable angina | 8 (9%) |
| Unstable angina | 3 (7.5%) |
| STEMI | 1 (2.5%) |
| NSTEMI | 1 (2.5%) |
| % diameter stenosis of MV in case of angio follow-up | 2.9 ± 3.4% |
| % diameter stenosis of SB | 11 ± 29.49% |
| Average duration from index procedure to the last follow-up (days) | 444 ± 303 |
| Binary restenosis MV | 0% |
| Binary restenosis SB | 1 (2.5%) |
| MV MLD | 3.2 ± 0.47 mm |
| SB MLD | 1.784 ± 0.6 mm |
| MV TLR | 0% |
| SB TLR | 0% |
| Aspirin at follow-up | 40 (100%) |
| P2Y12 inhibitors at follow-up | 25 (62.5%) |
| Death | 0% |
| CV death | 0% |
| Non CV death | 0% |
| TV MI | 1 (2.5%) |
| TV MI management | POBA |
| TLR | 0% |
| TVR | 1(2.5%) |
| Date of TVR | 10-4-2014 |
| TLR or TVR management | POBA |
| TL thrombosis | 0% |